EMETROL CHEWABLES- sodium citrate dihydrate tablet, chewable 
WellSpring Pharmaceutical Corporation

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Emetrol Chewables Rapid Nausea Relief

Active ingredients

Sodium citrate dihydrate USP 230 mg

Purpose

Upset stomach reliever/antacid

Uses

For the relief of nausea associated with upset/sour stomach, including that due to overindulgence in food and drink.

Warnings

Do not use if you have

Hereditary Fructose Intolerance (HFI). This product contains fructose.

Ask a doctor before use if you 

have diabetes because this product contains sugar
are on a sodium-restricted diet

Ask a doctor or pharmacist before use if

you are taking any other medications. This product may interact with certain prescription drugs.

When using this product,

do not take more than 24 tablets in a 24-hour period.

Stop use and ask a doctor if

nausea lasts more than two weeks or recurs frequently.

If pregnant or breast-feeding,

ask a health professional before use. In case of overdose, get medical help or contact a Poison Control Center right away.

Keep out of reach of children

Directions

Adults: 2-4 tablets.
Children: Consult a doctor for appropriate dosage.
Chew tablets completely. Do not swallow whole
Dosage may be repeated after 15 minutes, not to exceed 24 tablets in a 24-hour period unless advised by a doctor.
Read all package directions and warnings before use and use only as directed.
These tablets are intended for use by normally healthy persons only.
Persons under 18 years of age should use only as directed by a doctor.

Other information

Each table contains: Sodium 60mg
Store at room temperature
Protect product from excessive heat, cold and moisture
Note: This product is not intended as a substitute for a balanced nutritional diet or as an electrolyte replenishment.
Do not use if printed seal under cap is broken or missing.

Inactive ingredients

dextrose, flavor, fructose, hydroxypropyl cellulose, magnesium stearate, maltodextrin, silica, sodium carboxymethylcellulose, sucralose.

Questions or Comments?

1-844-241-5454 or Emetrol.com 

Distributed By

WellSpring Pharmaceutical Corporation
Sarasota, FL 34243
(c) 2022 WellSpring Pharmaceutical Corporation

PACKAGE LABEL

Pharmacy Recommended

New

Non-Drowsy

Emetrol Chewable Rapid Nausea Relief

Treats the source of Nausea*

*Due to overindulgence in food and drink

Powerful, Soothing Relief

Lemon Flavor

42 Chewable Tablets

Emetrol Chewable Nausea Relief

Side Panels

Emetrol Chewables Rapid Nausea Relief

Non-Drowsy

Treats the source of Nausea*

Specially Formulated for Adults

Great-tasting Lemon Chewables

*Due to overindulgence in food and drink

Emetrol Chewables relieves stomach discomfort with: 

No Acetaminophen

No Aspirin

No Caffeine

EMETROL CHEWABLES 
sodium citrate dihydrate tablet, chewable
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:65197-204
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) ANHYDROUS CITRIC ACID230 mg
Inactive Ingredients
Ingredient NameStrength
DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
LEMON (UNII: 24RS0A988O)  
FRUCTOSE (UNII: 6YSS42VSEV)  
HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED (UNII: K679OBS311)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
Product Characteristics
Colorwhite (White) Scoreno score
ShapeROUNDSize16mm
FlavorLEMONImprint Code CB2
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:65197-204-421 in 1 BOX03/15/2022
142 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other03/15/2022
Labeler - WellSpring Pharmaceutical Corporation (110999054)

Revised: 11/2023
Document Id: 052c21bb-93f9-4404-bb23-124a320cb364
Set id: 9880a18a-cf84-47cd-99b5-d692065a25bf
Version: 4
Effective Time: 20231121
 
WellSpring Pharmaceutical Corporation